Recruiting

Platelet StudiesNormal Donor Blood Draws for Platelet Studies and Biomarker Evaluation (ND-PLT)

Sponsor:

The Cleveland Clinic

Code:

NCT05628974

Conditions

Healthy

Eligibility Criteria

Sex: All

Age: 18 - 65

Healthy Volunteers: Not accepted

Study Details

Brief summary:

This is a single-center study at the Cleveland Clinic Main Campus designed to study biomarkers in healthy individuals to identify novel mechanisms of platelet activation and how platelets drive vascular inflammation and thrombosis in diseases.

Conditions

Healthy

Study ID

NCT05628974

Start date

May 1, 2020

Status verified date

Dec, 2025

Completion date

Jun 30, 2031

Anticipated

Primary completion date

Dec 31, 2030

Anticipated

Eligibility Criteria

Sex: All

Age: 18 - 65

Healthy Volunteers: Not accepted

Inclusion Criteria:

Adults aged 18 to 65 years old
Healthy Male \& Female voluntary participants

Exclusion Criteria:

Individuals who have taken anticoagulant or antiplatelet medications in past 10 days
Individuals with hematopoetic diseases

Study Design

Enrollment

400 participants

Anticipated

Interventions and Outcome Measures

Primary outcome measure

To collect blood samples [ Time Frame: 10 years ]

Central Contacts and Locations

Central contacts

Scott Cameron, MD, PhD

216-444-1680 cameros3@ccf.org

Locations

Cleveland Clinic

Recruiting

Cleveland, Ohio, United States, 44195

Contacts

Scott Cameron, MD, PhD

216-444-1680 cameros3@ccf.org

More Information

Sponsor

The Cleveland Clinic

Last update posted

Dec 16, 2025

Last verified

Dec, 2025

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by The Cleveland Clinic on 2025-12-16.